Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
BUZZ - Iambic Therapeutics, backed by Nvidia, surges on its first trading day after completing a $150 million IPO

BUZZ - Iambic Therapeutics, backed by Nvidia, surges on its first trading day after completing a $150 million IPO

路透社路透社2026/10/15 18:41
Show original

- ** Iambic Therapeutics (IAM.O) soared 19% to $19.08 on its first day of trading on Nasdaq after completing its $150 million US initial public offering (IPO)

** The drug development company backed by Nvidia opened at $16.15 per share, above its IPO issue price of $16

** San Diego, California-based IAM sold (link) 9.38 million shares at a price within the range of $15 to $17 per share (link)

** Despite overall volatility in the IPO market, the biotech sector remains a major highlight

** “At present, this seems more like a small bump rather than a three-car pileup… We’ve seen similar pullbacks before,” said Renaissance Capital senior strategist Matt Kennedy

** Iambic is leveraging its AI platform (link) to advance a range of drug candidates for the treatment of solid tumors


(To make news accessible for non-English speakers, Reuters provides automated translations of its reports in several languages. As automated translation may contain errors or lack context, Reuters does not guarantee the accuracy of these translations, which are provided for reader convenience. Reuters accepts no responsibility for any damage or loss arising from the use of automated translation.)

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

U.S. commercial crude oil inventories fell more than expected, with distillate inventories also declining and gasoline unexpectedly rising.

According to EIA data released on Thursday, for the week ending October 9, U.S. commercial crude oil inventories decreased by 8.6 million barrels to 415.6 million barrels, about 3% below the five-year average for the same period. Crude oil production fell by 300,000 barrels per day, and imports dropped by 791,000 barrels per day. Refinery crude runs increased by 135,000 barrels per day. Gasoline inventories rose by 3.5 million barrels, exceeding expectations, while distillate fuel inventories (including diesel and heating oil) decreased by 2.5 million barrels. The decline in crude inventories was mainly due to production shutdowns and reduced imports caused by a Gulf of Mexico hurricane.

华尔街见闻•2026/10/15 20:55
U.S. commercial crude oil inventories fell more than expected, with distillate inventories also declining and gasoline unexpectedly rising.